AFB (TB) – Antibiogram for MTb Complex – Ethionamide Drug by MGIT – Pure Growth of MTB Complex

This test measures the drug susceptibility of the Mycobacterium tuberculosis (MTb) complex to ethionamide.

• This test is mainly done to assess the drug susceptibility of the MTb complex to ethionamide, which guides the selection of appropriate anti-TB drugs for effective treatment. • It helps in avoiding drug resistance, improving treatment outcomes, and reducing transmission of TB.

This test is recommended for individuals with suspected or confirmed TB infection, especially when ethionamide therapy is being considered. It is also useful for patients who have not responded to initial anti-TB treatment or have a history of drug-resistant TB.

Abnormal results indicate that the bacteria is resistant to ethionamide, which may point towards the need for alternative anti-TB drugs or a different treatment approach.

Please reach out to your healthcare provider for any specific requirements.

• Sputum Smear Microscopy: This test helps in the initial diagnosis of TB by examining a sputum sample under a microscope for the presence of acid-fast bacilli. • GeneXpert MTB/RIF: This molecular test detects the presence of MTb and evaluates resistance to rifampicin, another important anti-TB drug.

Antibiogram for Mycobacterium tuberculosis (MTb) complex, Ethionamide Drug Susceptibility Testing for TB, Ethionamide Sensitivity Testing

Tuberculosis (TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other parts of the body. TB can cause symptoms such as coughing, fever, weight loss, and fatigue. Prompt diagnosis and treatment are essential to prevent complications and stop the spread of the disease.